StonvexLoading…
StonvexStonvexStonvexCore line items from INIS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $13.07M | $10.17M | $6.89M | $3.24M |
Operating Income | $-956.19K | $-381.27K | $-199.86K | $-65.02K |
Net Income | $-908.00K | $-477.08K | $-273.48K | $-112.69K |
EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 |
Total Assets | $17.84M | $17.85M | $17.51M | $17.57M |
Total Liabilities | $14.14M | $13.75M | $13.24M | $13.23M |
Cash & Equivalents | $1.70M | $1.65M | $1.86M | $1.65M |
Free Cash Flow OCF − CapEx | $86.01K | $-44.35K | $120.07K | $-134.00K |
Shares Outstanding | 528.21M | 528.10M | 528.01M | 524.79M |